Abstract

This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

Original languageEnglish
Pages (from-to)10-23
Number of pages14
JournalDigestive and Liver Disease
Volume51
Issue number1
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Immunocompromised Host
Antiviral Agents
Infection

Keywords

  • HCV
  • Immunocompromised patients
  • Organ transplant

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

AISF position paper on HCV in immunocompromised patients. / Italian Association for the Study of the Liver (AISF).

In: Digestive and Liver Disease, Vol. 51, No. 1, 01.01.2019, p. 10-23.

Research output: Contribution to journalArticle

Italian Association for the Study of the Liver (AISF) 2019, 'AISF position paper on HCV in immunocompromised patients' Digestive and Liver Disease, vol. 51, no. 1, pp. 10-23. https://doi.org/10.1016/j.dld.2018.09.022
Italian Association for the Study of the Liver (AISF). AISF position paper on HCV in immunocompromised patients. Digestive and Liver Disease. 2019 Jan 1;51(1):10-23. https://doi.org/10.1016/j.dld.2018.09.022
Italian Association for the Study of the Liver (AISF). / AISF position paper on HCV in immunocompromised patients. In: Digestive and Liver Disease. 2019 ; Vol. 51, No. 1. pp. 10-23.
@article{057cf8f50b4f4c06b3e4fd458ea98a7d,
title = "AISF position paper on HCV in immunocompromised patients",
abstract = "This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.",
keywords = "HCV, Immunocompromised patients, Organ transplant",
author = "{Italian Association for the Study of the Liver (AISF)} and Alfredo Marzano and Emanuele Angelucci and Marco Astegiano and Chiara Baratelli and Luigi Biancone and Paolo Bironzo and Giuseppina Brancaccio and Brunetto, {Maurizia Rossana} and Raffaele Bruno and Patrizia Burra and Cabras, {Maria Giuseppina} and Paolo Caraceni and Claudia Chial{\`a} and Clemente, {Maria Grazia} and Agostino Colli and Bruno Daniele and {De Gasperi}, Elisabetta and {Di Marco}, Vito and Ditto, {Maria Chiara} and Stefano Fagiuoli and Clodoveo Ferri and Gaeta, {Giovanni Battista} and Grossi, {Paolo Antonio} and Barbara Imperatrice and Pietro Lampertico and Macaluso, {Fabio Salvatore} and Salvatore Madonia and Massimo Marignani and Chiara Mazzarelli and Alberto Mella and Gabriele Missale and Simone Parisi and Luisa Pasulo and Massimo Puoti and Maria Rendina and Davide Ribaldone and Giuseppe Rossi and Pierluigi Toniutto and Alessandra Tucci and Pietro Vajro and Mauro Vigan{\`o} and Riccardo Volpes and Zignego, {Anna Linda} and Giannini, {Edoardo G.} and Luca Miele and Russo, {Francesco Paolo} and Salvatore Petta and {Di Maio}, Massimo and Mario Rizzetto and Giuliano Torre",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.dld.2018.09.022",
language = "English",
volume = "51",
pages = "10--23",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - AISF position paper on HCV in immunocompromised patients

AU - Italian Association for the Study of the Liver (AISF)

AU - Marzano, Alfredo

AU - Angelucci, Emanuele

AU - Astegiano, Marco

AU - Baratelli, Chiara

AU - Biancone, Luigi

AU - Bironzo, Paolo

AU - Brancaccio, Giuseppina

AU - Brunetto, Maurizia Rossana

AU - Bruno, Raffaele

AU - Burra, Patrizia

AU - Cabras, Maria Giuseppina

AU - Caraceni, Paolo

AU - Chialà, Claudia

AU - Clemente, Maria Grazia

AU - Colli, Agostino

AU - Daniele, Bruno

AU - De Gasperi, Elisabetta

AU - Di Marco, Vito

AU - Ditto, Maria Chiara

AU - Fagiuoli, Stefano

AU - Ferri, Clodoveo

AU - Gaeta, Giovanni Battista

AU - Grossi, Paolo Antonio

AU - Imperatrice, Barbara

AU - Lampertico, Pietro

AU - Macaluso, Fabio Salvatore

AU - Madonia, Salvatore

AU - Marignani, Massimo

AU - Mazzarelli, Chiara

AU - Mella, Alberto

AU - Missale, Gabriele

AU - Parisi, Simone

AU - Pasulo, Luisa

AU - Puoti, Massimo

AU - Rendina, Maria

AU - Ribaldone, Davide

AU - Rossi, Giuseppe

AU - Toniutto, Pierluigi

AU - Tucci, Alessandra

AU - Vajro, Pietro

AU - Viganò, Mauro

AU - Volpes, Riccardo

AU - Zignego, Anna Linda

AU - Giannini, Edoardo G.

AU - Miele, Luca

AU - Russo, Francesco Paolo

AU - Petta, Salvatore

AU - Di Maio, Massimo

AU - Rizzetto, Mario

AU - Torre, Giuliano

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

AB - This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

KW - HCV

KW - Immunocompromised patients

KW - Organ transplant

UR - http://www.scopus.com/inward/record.url?scp=85055187232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055187232&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2018.09.022

DO - 10.1016/j.dld.2018.09.022

M3 - Article

VL - 51

SP - 10

EP - 23

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 1

ER -